Detailed Information on Publication Record
2020
Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours
VLASÁK, Pavel, Jiří BOUDA, Jan KOSTUN, Denis BEREZOVSKIY, Michal ZIKÁN et. al.Basic information
Original name
Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours
Authors
VLASÁK, Pavel (203 Czech Republic), Jiří BOUDA (203 Czech Republic), Jan KOSTUN (203 Czech Republic), Denis BEREZOVSKIY (203 Czech Republic), Michal ZIKÁN (203 Czech Republic), Vít WEINBERGER (203 Czech Republic, belonging to the institution), Ondrej ONDIC (203 Czech Republic), Zdeněk RUŠAVÝ (203 Czech Republic), Radek KUČERA (203 Czech Republic), Ondřej TOPOLČAN (203 Czech Republic), Zdeněk NOVOTNÝ (203 Czech Republic) and Jiří PRESL (203 Czech Republic, guarantor)
Edition
Anticancer Research, Athens, Greece, 2020, 0250-7005
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Greece
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.480
RIV identification code
RIV/00216224:14110/20:00115742
Organization unit
Faculty of Medicine
UT WoS
000538104800060
Keywords in English
Tru-Cut biopsy; ovarian cancer; ascites; puncture
Tags
International impact, Reviewed
Změněno: 1/4/2021 14:08, Mgr. Tereza Miškechová
Abstract
V originále
Background/Aim: To compare the diagnostic reliability, accuracy and safety of ultrasound-guided biopsy (Tru-Cut biopsy) and ascites puncture in patients with a primarily inoperable malignant ovarian tumor. Patients and Methods: This is a retrospective analysis of the studied methods in consecutively examined patients and a prospective validation of these methods. 79 women with a suspected primarily inoperable ovarian tumor underwent Tru-Cut biopsies and were included in the ultrasound-guided biopsy group. In addition, 55 patients after ascites puncture were enrolled in the comparison group. Both procedures were performed in 48 patients for the prospective validation. Results: Significant differences in favour of ultrasound-guided biopsy were found in all studied variables (malignancy confirmation 72.9% vs. 95.8%, tumor origin 52.1% vs. 89.6%, histologic subtype 43.8% vs. 85.4% and accuracy, i.e. agreement of preoperative and definitive diagnosis 43.7% vs. 95.4%). Conclusion: Ultrasound-guided biopsy is an accurate, reliable, safe and minimally invasive method. Owing to the high reliability and accuracy, it has the capacity to replace ascites puncture with cytologic examination or a more invasive method (laparoscopy, laparotomy) for adequate tumor sampling.